{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T18:11:58Z","timestamp":1776795118484,"version":"3.51.2"},"reference-count":34,"publisher":"Bentham Science Publishers Ltd.","issue":"1","funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82273094"],"award-info":[{"award-number":["82273094"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Hubei Key Laboratory Opening Project","award":["2021KFY064"],"award-info":[{"award-number":["2021KFY064"]}]}],"content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CMM"],"published-print":{"date-parts":[[2026,1]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Gastric cancer (GC) remains a major health burden with poor\nprognosis, highlighting the need for reliable prognostic biomarkers and therapeutic\ntargets. ELOVL4 (Elongation of Very Long Chain Fatty Acids Protein 4) is an enzyme\ninvolved in lipid metabolism, which has been implicated in various cancers, but its role\nin GC remains largely unexplored.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>We evaluated the prognostic value of ELOVL4 expression in GC based on\nsamples from The Cancer Genome Atlas (TCGA) database. Subsequently, we\ninvestigated the associations between ELOVL4 expression and tumor immune\nmicroenvironment features, including tumor microenvironment (TME) scores, immune\ncell infiltration, and immune checkpoint gene expression. Moreover, we assessed the\ncorrelation between ELOVL4 expression and tumor mutational burden (TMB) as well\nas drug sensitivity profiles. Functional and pathway enrichment analyses were\nperformed to gain mechanistic insights.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results and Discussion:<\/jats:title>\n                    <jats:p>High ELOVL4 expression was significantly associated with adverse clinical\noutcomes. A nomogram incorporating ELOVL4 expression was developed for\nindividualized prognosis evaluation. Patients with high ELOVL4 expression exhibited\nan activated TME, with distinct immune cell infiltration patterns and correlations with\nimmune checkpoint gene expression. Additionally, ELOVL4 expression was negatively\ncorrelated with TMB. Differential drug sensitivity profiles were identified between the\nhigh and low ELOVL4 expression groups. Enrichment analyses revealed the\ninvolvement of ELOVL4 in various biological processes and signaling pathways.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>Our findings establish ELOVL4 as a biomarker for poor prognosis and\ntherapeutic target in GC, with implications for prognosis evaluation, immune\nmicroenvironment modulation, and chemotherapeutic response.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.2174\/0115665240356824250116103049","type":"journal-article","created":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T11:24:12Z","timestamp":1759404252000},"page":"99-112","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["ELOVL4 is a Prognostic Biomarker with Implications for Immune Modulation and Therapeutic Response in Gastric Cancer"],"prefix":"10.2174","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5526-997X","authenticated-orcid":true,"given":"Yuxin","family":"Chu","sequence":"first","affiliation":[{"name":"Department of Radiotherapy, Cancer Center, Renmin Hospital of Wuhan University, Wuhan, 430060, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2601-9423","authenticated-orcid":true,"given":"Yi","family":"Yao","sequence":"additional","affiliation":[{"name":"Department of Radiotherapy, Cancer Center, Renmin Hospital of Wuhan University, Wuhan, 430060, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2387-6438","authenticated-orcid":true,"given":"Qibin","family":"Song","sequence":"additional","affiliation":[{"name":"Department of Radiotherapy, Cancer Center, Renmin Hospital of Wuhan University, Wuhan, 430060, China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"e2118457","DOI":"10.1001\/jamanetworkopen.2021.18457","volume":"4","author":"Wong M.C.S.","year":"2021","unstructured":"Wong M.C.S.; Huang J.; Chan P.S.F.; Global incidence and mortality of gastric cancer, 1980-2018. JAMA Netw Open  2021,4(7),e2118457","journal-title":"JAMA Netw Open"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1002\/ijc.30835","volume":"141","author":"Luo G.","year":"2017","unstructured":"Luo G.; Zhang Y.; Guo P.; Wang L.; Huang Y.; Li K.; Global patterns and trends in stomach cancer incidence: Age, period and birth cohort analysis. Int J Cancer  2017,141(7),1333-1344","journal-title":"Int J Cancer"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"81","DOI":"10.21147\/j.issn.1000-9604.2023.02.01","volume":"35","author":"Yan X.","year":"2023","unstructured":"Yan X.; Lei L.; Li H.; Stomach cancer burden in China: Epidemiology and prevention. Chin J Cancer Res  2023,35(2),81-91","journal-title":"Chin J Cancer Res"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"26","DOI":"10.5114\/pg.2018.80001","volume":"14","author":"Rawla P.","year":"2019","unstructured":"Rawla P.; Barsouk A.; Epidemiology of gastric cancer: Global trends, risk factors and prevention. Prz Gastroenterol  2019,14(1),26-38","journal-title":"Prz Gastroenterol"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1038\/s41419-022-04821-w","volume":"13","author":"Zhao L.","year":"2022","unstructured":"Zhao L.; Liu Y.; Zhang S.; Impacts and mechanisms of metabolic reprogramming of tumor microenvironment for immunotherapy in gastric cancer. Cell Death Dis  2022,13(4),378","journal-title":"Cell Death Dis"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1002\/mco2.27","volume":"2","author":"Fu Y","year":"2020","unstructured":"Fu Y; Zou T; Shen X; Lipid metabolism in cancer progression and therapeutic strategies MedComm (2020)  2020,2(1),27-59"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"100030","DOI":"10.1016\/j.jlr.2021.100030","volume":"62","author":"Yeboah G.K.","year":"2021","unstructured":"Yeboah G.K.; Lobanova E.S.; Brush R.S.; Agbaga M.P.; Very long chain fatty acid-containing lipids: A decade of novel insights from the study of ELOVL4. J Lipid Res  2021,62,100030","journal-title":"J Lipid Res"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"1218","DOI":"10.2337\/db21-0640","volume":"71","author":"Castell A.L.","year":"2022","unstructured":"Castell A.L.; Vivoli A.; Tippetts T.S.; Very-long-chain unsaturated sphingolipids mediate oleate-induced rat \u03b2-cell proliferation. Diabetes  2022,71(6),1218-1232","journal-title":"Diabetes"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/j.addr.2020.01.004","volume":"159","author":"Bogie J.F.J.","year":"2020","unstructured":"Bogie J.F.J.; Haidar M.; Kooij G.; Hendriks J.J.A.; Fatty acid metabolism in the progression and resolution of CNS disorders. Adv Drug Deliv Rev  2020,159,198-213","journal-title":"Adv Drug Deliv Rev"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"5741","DOI":"10.1038\/s41388-021-01959-3","volume":"40","author":"Rugolo F.","year":"2021","unstructured":"Rugolo F.; Bazan N.G.; Calandria J.; The expression of ELOVL4, repressed by MYCN, defines neuroblastoma patients with good outcome. Oncogene  2021,40(38),5741-5751","journal-title":"Oncogene"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1186\/s40001-023-01523-7","volume":"28","author":"Wang X.","year":"2023","unstructured":"Wang X.; Yu H.; Gao R.; Liu M.; Xie W.; A comprehensive review of the family of very-long-chain fatty acid elongases: structure, function, and implications in physiology and pathology. Eur J Med Res  2023,28(1),532","journal-title":"Eur J Med Res"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1007\/s10555-022-10040-8","volume":"41","author":"Agostini M.","year":"2022","unstructured":"Agostini M.; Melino G.; Habeb B.; Calandria J.M.; Bazan N.G.; Targeting lipid metabolism in cancer. Neuroblastoma Cancer Metastasis Rev  2022,41(2),255-260","journal-title":"Neuroblastoma Cancer Metastasis Rev"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1186\/s12885-020-06814-4","volume":"20","author":"Yoon S.J.","year":"2020","unstructured":"Yoon S.J.; Park J.; Shin Y.; Deconvolution of diffuse gastric cancer and the suppression of CD34 on the BALB\/c nude mice model. BMC Cancer  2020,20(1),314","journal-title":"BMC Cancer"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.1007\/s10495-023-01868-8","volume":"28","author":"Shi Y.","year":"2023","unstructured":"Shi Y.; Wang Y.; Dong H.; Crosstalk of ferroptosis regulators and tumor immunity in pancreatic adenocarcinoma: Novel perspective to mRNA vaccines and personalized immunotherapy. Apoptosis  2023,28(9-10),1423-1435","journal-title":"Apoptosis"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"2612","DOI":"10.1038\/ncomms3612","volume":"4","author":"Yoshihara K.","year":"2013","unstructured":"Yoshihara K.; Shahmoradgoli M.; Mart\u00ednez E.; Inferring tumour purity and stromal and immune cell admixture from expression data. Nat Commun  2013,4(1),2612","journal-title":"Nat Commun"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1007\/978-1-4939-7493-1_12","volume":"1711","author":"Chen B.","year":"2018","unstructured":"Chen B.; Khodadoust M.S.; Liu C.L.; Newman A.M.; Alizadeh A.A.; Profiling tumor infiltrating immune cells with CIBERSORT. Methods Mol Biol  2018,1711,243-259","journal-title":"Methods Mol Biol"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"bbab260","DOI":"10.1093\/bib\/bbab260","volume":"22","author":"Maeser D.","year":"2021","unstructured":"Maeser D.; Gruener R.F.; Huang R.S.; oncoPredict: An R package for predicting in vivo or cancer patient drug response and biomarkers from cell line screening data. Brief Bioinform  2021,22(6),bbab260","journal-title":"Brief Bioinform"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"e47","DOI":"10.1093\/nar\/gkv007","volume":"43","author":"Ritchie M.E.","year":"2015","unstructured":"Ritchie M.E.; Phipson B.; Wu D.; limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res  2015,43(7),e47","journal-title":"Nucleic Acids Res"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1089\/omi.2011.0118","volume":"16","author":"Yu G.","year":"2012","unstructured":"Yu G.; Wang L.G.; Han Y.; He Q.Y.; clusterProfiler: An R package for comparing biological themes among gene clusters. OMICS  2012,16(5),284-287","journal-title":"OMICS"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"17158","DOI":"10.1038\/s41598-024-67549-x","volume":"14","author":"Wang Y.","year":"2024","unstructured":"Wang Y.; Yao J.; Zhang Z.; Wei L.; Wang S.; Generation of novel lipid metabolism-based signatures to predict prognosis and immunotherapy response for colorectal adenocarcinoma. Sci Rep  2024,14(1),17158","journal-title":"Sci Rep"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"769","DOI":"10.2337\/db17-1034","volume":"67","author":"Kady N.M.","year":"2018","unstructured":"Kady N.M.; Liu X.; Lydic T.A.; ELOVL4-mediated production of very long-chain ceramides stabilizes tight junctions and prevents diabetes-induced retinal vascular permeability. Diabetes  2018,67(4),769-781","journal-title":"Diabetes"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"834","DOI":"10.21037\/atm-22-3530","volume":"10","author":"Gong Y.","year":"2022","unstructured":"Gong Y.; Liu X.; Sahu A.; Reddy A.V.; Wang H.; Exploration of hub genes, lipid metabolism, and the immune microenvironment in stomach carcinoma and cholangiocarcinoma. Ann Transl Med  2022,10(15),834","journal-title":"Ann Transl Med"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1186\/s13045-021-01200-4","volume":"14","author":"Yu W.","year":"2021","unstructured":"Yu W.; Lei Q.; Yang L.; Contradictory roles of lipid metabolism in immune response within the tumor microenvironment. J Hematol Oncol  2021,14(1),187","journal-title":"J Hematol Oncol"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"3596","DOI":"10.7150\/jca.91842","volume":"15","author":"Bian G.","year":"2024","unstructured":"Bian G.; Cao J.; Li W.; Identification and validation of a cancer-testis antigen-related signature to predict the prognosis in stomach adenocarcinoma. J Cancer  2024,15(11),3596-3611","journal-title":"J Cancer"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"12032","DOI":"10.3390\/ijms241512032","volume":"24","author":"Vassiliou E.","year":"2023","unstructured":"Vassiliou E.; Farias-Pereira R.; Impact of lipid metabolism on macrophage polarization: Implications for inflammation and tumor immunity. Int J Mol Sci  2023,24(15),12032","journal-title":"Int J Mol Sci"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"840440","DOI":"10.3389\/fphar.2022.840440","volume":"13","author":"Tu B.","year":"2022","unstructured":"Tu B.; Gao Y.; Sun F.; Shi M.; Huang Y.; Lipid metabolism regulation based on nanotechnology for enhancement of tumor immunity. Front Pharmacol  2022,13,840440","journal-title":"Front Pharmacol"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1038\/nri.2017.76","volume":"18","author":"Papalexi E.","year":"2018","unstructured":"Papalexi E.; Satija R.; Single-cell RNA sequencing to explore immune cell heterogeneity. Nat Rev Immunol  2018,18(1),35-45","journal-title":"Nat Rev Immunol"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.semcancer.2019.11.011","volume":"65","author":"Kobayashi Y.","year":"2020","unstructured":"Kobayashi Y.; Lim S.O.; Yamaguchi H.; Oncogenic signaling pathways associated with immune evasion and resistance to immune checkpoint inhibitors in cancer. Semin Cancer Biol  2020,65,51-64","journal-title":"Semin Cancer Biol"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1038\/s41417-020-0174-y","volume":"27","author":"Choucair K.","year":"2020","unstructured":"Choucair K.; Morand S.; Stanbery L.; Edelman G.; Dworkin L.; Nemunaitis J.; TMB: A promising immune-response biomarker, and potential spearhead in advancing targeted therapy trials. Cancer Gene Ther  2020,27(12),841-853","journal-title":"Cancer Gene Ther"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.3390\/nu16081102","volume":"16","author":"Wang Y.","year":"2024","unstructured":"Wang Y.; Li Z.; He J.; Zhao Y.; Quercetin regulates lipid metabolism and fat accumulation by regulating inflammatory responses and glycometabolism pathways: A review. Nutrients  2024,16(8),1102","journal-title":"Nutrients"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"428","DOI":"10.3389\/fncel.2019.00428","volume":"13","author":"De\u00e1k F.","year":"2019","unstructured":"De\u00e1k F.; Anderson R.E.; Fessler J.L.; Sherry D.M.; Novel cellular functions of very long chain-fatty acids: Insight from ELOVL4 mutations. Front Cell Neurosci  2019,13,428","journal-title":"Front Cell Neurosci"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"984560","DOI":"10.3389\/fonc.2022.984560","volume":"12","author":"Wang D.","year":"2022","unstructured":"Wang D.; Ye Q.; Gu H.; Chen Z.; The role of lipid metabolism in tumor immune microenvironment and potential therapeutic strategies. Front Oncol  2022,12,984560","journal-title":"Front Oncol"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"e18128","DOI":"10.1016\/j.heliyon.2023.e18128","volume":"9","author":"Xia Z.","year":"2023","unstructured":"Xia Z.; Zhao N.; Liu M.; GPD1 inhibits the carcinogenesis of breast cancer through increasing PI3K\/AKT-mediated lipid metabolism signaling pathway. Heliyon  2023,9(7),e18128","journal-title":"Heliyon"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"3899","DOI":"10.3390\/nu15183899","volume":"15","author":"Garcia C.","year":"2023","unstructured":"Garcia C.; Andersen C.J.; Blesso C.N.; The role of lipids in the regulation of immune responses. Nutrients  2023,15(18),3899","journal-title":"Nutrients"}],"container-title":["Current Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0115665240356824250116103049","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/245743\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0115665240356824250116103049","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T07:43:11Z","timestamp":1776757391000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/245743\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":34,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/0115665240356824250116103049","relation":{},"ISSN":["1566-5240"],"issn-type":[{"value":"1566-5240","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Double blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2024-09-29","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-12-06","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-12-07","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-03-19","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}